Skip to content

Using Community Health Navigators to Advance Cancer Screening Adherence

Using Community Health Navigators to Advance Cancer Screening Adherence Through Videoconferencing for All Americans Who Use ASL: A Randomized Controlled Trial Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06492993
Enrollment
184
Registered
2024-07-09
Start date
2023-09-30
Completion date
2026-03-20
Last updated
2026-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Deafness

Brief summary

Intervention to promote cancer screenings among deaf, deafblind, and hard of hearing participants who have not received screening within the recommended guideline.

Detailed description

Study hypothesizes that the intervention that involves utilization of a DDBHH CHN will result in (i) DDBHH patients demonstrating greater adherence to screening compared to DDBHH patients who were assigned to the standard of care group , and (ii) higher patient-physician communication rating by DDBHH patients compared to DDBHH patients who were assigned to the standard of care group. Bilingual ASL-English measures (e.g., sociodemographics, cancer knowledge, patient-physician communication) will be administered to the participant at baseline data collection and again after the final data collection or by 11 months for comparison.

Interventions

OTHEREducation

The CHN meets with DDBHH participant over sessions to provide navigation support through the cancer screening process.

Sponsors

Gallaudet University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SCREENING
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
45 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Provision of signed and dated informed consent form Stated willingness to comply with all study procedures and lifestyle considerations (see Section 5.3, Lifestyle Considerations) and availability for the duration of the study Male or female at birth age 45-80yo or female at birth age 45-80yo; age-eligible according to screening criteria Self-reported diagnosis of bilateral hearing loss at birth or prior to 13 years old (defined as "early deafness") and use ASL Willingness to adhere to the CHN clinical trial regimen Willingness to provide cancer screening verification documentation; this will be reviewed during the informed consent procedure Access to necessary resources to support video-based communication Non-adherent to one or more cancer screening guidelines for breast, lung, prostate, colon, cervical cancers will be those who reported not having had the appropriate recommended screenings within the past year to cancer screening questions in the HINTS-ASL survey

Exclusion criteria

* Presence of full ability to hear in one or both ears beyond 13 years of age Younger or older than the age cutoff for the recommended cancer screening Not capable of independently conducting the activities of daily living In compliance with age- or risk-specific screening at the time of evaluation for study eligibility Are currently undergoing cancer treatment or being evaluated for the presence of cancer at the time of evaluation for study eligibility Will be engaged in more than 21 consecutive days of travel during the eleven-month study window Knows other participants at baseline

Design outcomes

Primary

MeasureTime frameDescription
Number of participants who are adherent to cancer screening9 monthsCompletion of at least one recommended cancer screening as measured by documentation of the actual screening

Secondary

MeasureTime frameDescription
Percent of participants who demonstrate high cancer knowledge and high perceived patient centered care9 monthsPositive change in patient-physician communication and cancer knowledge from baseline to closeout as defined by the participating patient.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORPoorna Kushalnagar

Gallaudet University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026